Article Text

other Versions

Download PDFPDF
Response to: Correspondence on ‘Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank’ by Jolobe
  1. Zahra Raisi-Estabragh1,2,
  2. Nicholas C Harvey3,4,
  3. Steffen E Petersen1,2,5,6
  1. 1William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK
  2. 2Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust, London, UK
  3. 3MRC Lifecourse Epidemiology Centre, University of Southampton, Southampton, UK
  4. 4NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK
  5. 5Health Data Research UK, London, UK
  6. 6Alan Turing Institute, London, UK
  1. Correspondence to Dr Zahra Raisi-Estabragh, Queen Mary University of London, London E1 4NS, UK; zahraraisi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Authors' reply We read with interest the response to our study evaluating cardiovascular sequelae of COVID-19 in the UK Biobank. Our analysis of 17 871 UK Biobank participants with past COVID-19 demonstrated increased risk of first occurrence of a range of cardiovascular diseases compared with uninfected controls, particularly in those requiring hospitalisation for COVID-19.1 While we did not specifically examine the burden of mechanical …

View Full Text


  • Twitter @zahra_raisi

  • Contributors ZR-E, NCH and SEP jointly wrote and approved the response letter.

  • Funding This study was funded by the British Heart Foundation (FS/17/81/33318, PG/21/10619).

  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles